Navigation Links
VaxInnate to discuss seasonal and pandemic flu vaccines during BIO 2008 this week
Date:6/15/2008

SAN DIEGO, CA, June 16, 2008 -- VaxInnate Corporation announced today that it will discuss its novel proprietary technology for producing seasonal and pandemic influenza vaccines during BIO 2008 here this week.

VaxInnate will participate in the following three BIO 2008 panel discussions:

On Tuesday, June 17th

  • "Influenza Research and Surveillance: Preparing for the Next Pandemic,"
    8:15-9:45 am in Room 29A including Robert Becker, PhD, MBA, VaxInnate's Vice President of Business Development

On Thursday, June 19th

  • "Vaccine Renaissance,"
    8:30-10:00 am, Room 29A including Dr. Robert Becker

  • "Moore's Law for Biomanufacturing: Innovation in a Maturing Biologicals Industry,"
    4:00 - 5:30 pm, Room 29B including Edward Arcuri, PhD, VaxInnate's Chief of Operations (COO)

VaxInnate's Approach

VaxInnate's novel technology has the potential to dramatically improve the potency, manufacturing capacity and cost-effectiveness of influenza vaccines.

VaxInnate's approach to developing and producing influenza vaccines is based upon a proprietary combination of toll-like receptor (TLR) mediated immune enhancement and recombinant bacterial production of vaccine antigen. This proprietary technology could significantly reduce the time required to produce supplies of influenza vaccine sufficient to meet national and even global needs.

VaxInnate's use of bacterial expression for production of influenza vaccines does not require costly expansion of manufacturing capacity, as do other influenza vaccine products. Due to its efficiency and transferability, VaxInnate's flu vaccine could instead be produced in existing biotechnology facilities that have microbial production capacity.

No other vaccine technology in use or in development today has these same potential capabilities.

Results of a Phase I study of VaxInnate's M2e universal vaccine candidate will be available this summer. The company plans to present the study data at a major scientific conference later this year and publish the data in a peer-reviewed journal.


'/>"/>

Contact: Janet Skidmore
skidmorecomm@earthlink.net
215-658-4915
VaxInnate
Source:Eurekalert

Related biology news :

1. Scientists, policymakers and industry leaders gather to discuss ocean iron fertilization
2. Book on weeds and invasive plants discusses how to manage them using ecological approaches
3. Presidents of Iceland, Bangladesh to discuss global climate change in New Orleans
4. Art meets science: Engineer discusses his photographs in free UH lecture
5. Leading researchers and experts gather to discuss latest advancements in drug discovery
6. Japanese and German researchers meet to discuss climate change
7. Biophysical Society to host discussions on the teaching of evolution and on the energy crisis
8. MIT professor to discuss future of biofuels
9. DHS, business leaders discuss technology to protect US at Homeland Security conference
10. Wildlife Conservation Society study finds seasonal seas save corals with tough love
11. NASA technology helps predict and prevent future pandemic outbreaks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2016)... y TORONTO , 19 de diciembre de 2016 ... Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado ... tipos de tumor en 2017, con múltiples sitios previstos a lo ... ... objetivo en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica ...
(Date:12/15/2016)... 15, 2016   WaferGen Bio-systems, Inc. (NASDAQ: ... company, announced today that on December 13, 2016, it ... The Nasdaq Stock Market LLC which acknowledged that, as ... WaferGen,s common stock had been at $1.00 or greater ... compliance with Listing Rule 5550(a)(2) of the Nasdaq Stock ...
(Date:12/12/2016)... Dec. 12, 2016  Researchers at Trinity College, ... graphene by combining the material with Silly Putty. The ... pressure detector able to sense pulse, blood pressure, ... spider.  The research team,s findings ... read here:  http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):
(Date:1/17/2017)... MA (PRWEB) , ... January 17, 2017 , ... ... the completely re-engineered Drug Safety Technology Consortium™ (SafeTEC™), $3 million in investment towards ... validating these new tools and assays, and their applicability in drug safety assessment, ...
(Date:1/16/2017)... ... January 16, 2017 , ... Appellate Court ... decision on the appeal filed by India-based Dishman Pharmaceutical & Chemical Ltd. company ... DPCL and one of its Dishman Group’s 100% wholly owned New Jersey-based subsidiary ...
(Date:1/14/2017)...  The Alliance for Safe Biologic Medicines (ASBM) today ... final guidance on biologic naming: We ... the importance of distinct naming for all biologics, including ... biosimilars will bring to patients, including new treatment options ... of the Guidance dealing with suffix design remains at ...
(Date:1/13/2017)... ... January 13, 2017 , ... FireflySci, in response to several ... new solutions for measurements where traditional cuvette applications are not convenient. For instance, ... oddly-shaped sample that would not fit into a typical cuvette inside a spectrophotometer. ...
Breaking Biology Technology: